← back to search

Reinhold Munker

Tulane University · US
Area of research
Hematology · Pathology and Forensic Medicine
Research interest
Research interests include Medicine, Internal medicine, Transplantation, Hazard ratio, Hematopoietic cell, and Hematopoietic stem cell transplantation.
h-index
citations
878
works
18
NIH funding
primary concept
email

Recent publications

CTNI-39. TIRABRUTINIB FOR THE TREATMENT OF RELAPSED OR REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: EFFICACY AND SAFETY FROM THE PHASE II PROSPECT STUDY
Neuro-Oncology 2025cited by 0position: middledoi
Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minorities
Blood Advances 2024cited by 19position: middledoi
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis
Haematologica 2023cited by 29position: middledoi
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis
Haematologica 2022cited by 26position: middledoi
Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research
Transplantation and Cellular Therapy 2022cited by 23position: middledoi
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia
Blood Advances 2021cited by 76position: middledoi
Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation
Bone Marrow Transplantation 2021cited by 20position: middledoi
Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era
Leukemia 2020cited by 37position: middledoi
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission
Blood Advances 2019cited by 128position: middledoi
Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research
Haematologica 2019cited by 37position: middledoi
Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases
Haematologica 2017cited by 60position: middledoi
HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research
Biology of Blood and Marrow Transplantation 2015cited by 100position: middledoi
The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen
Biology of Blood and Marrow Transplantation 2015cited by 53position: middledoi
Impact of Pretransplantation 18F-fluorodeoxy Glucose–Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma
Biology of Blood and Marrow Transplantation 2015cited by 39position: middledoi
Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation
Bone Marrow Transplantation 2015cited by 38position: middledoi
Outcomes of Hematopoietic Cell Transplantation for Diffuse Large B Cell Lymphoma Transformed from Follicular Lymphoma
Biology of Blood and Marrow Transplantation 2014cited by 42position: middledoi
Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor
Bone Marrow Transplantation 2014cited by 42position: middledoi
Salvage Second Hematopoietic Cell Transplantation in Myeloma
Biology of Blood and Marrow Transplantation 2013cited by 109position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jörg Dietrich · Harvard University1 papers (2025–2025)Ugonma Chukwueke · University of Alabama at Birmingham1 papers (2025–2025) · 1 papers (2025–2025)Wael Saber · Benha University1 papers (2015–2015)Stephen R. Spellman · Memorial Sloan Kettering Cancer Center1 papers (2015–2015)Dawit Aregawi · Pennsylvania State University1 papers (2025–2025)Tracy T. Batchelor · Harvard University1 papers (2025–2025)Minoo Battiwalla · Roswell Park Comprehensive Cancer Center1 papers (2015–2015)David M. Peereboom · Advocate Health Care1 papers (2025–2025)Mahmoud Aljurf · Erciyes University1 papers (2015–2015)Fábio M. Iwamoto · Cornell University1 papers (2025–2025) · 1 papers (2025–2025)Joseph Pidala · Indiana University – Purdue University Indianapolis1 papers (2015–2015)Kwang Woo Ahn · Medical College of Wisconsin1 papers (2015–2015)Prakash Ambady · Legacy Health1 papers (2025–2025) · 1 papers (2015–2015)Christian Grommes · Weill Cornell Medical College in Qatar1 papers (2025–2025)Michael R. Verneris · University of Colorado Anschutz Medical Campus1 papers (2015–2015)Joe Mendez · University of Utah1 papers (2025–2025)Marcelo Fernández-Viña · Palo Alto University1 papers (2015–2015)